Is 17α‐hydroxyprogesterone caproate contraindicated in twin gestations?
暂无分享,去创建一个
[1] K. Nicolaides,et al. Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta‐analysis , 2015, BJOG : an international journal of obstetrics and gynaecology.
[2] B. Mol,et al. Cervical pessaries for prevention of preterm birth in women with a multiple pregnancy (ProTWIN): a multicentre, open-label randomised controlled trial , 2013, The Lancet.
[3] R. Romero,et al. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice. , 2013, American journal of obstetrics and gynecology.
[4] Roberto Romero. Progesterone to prevent preterm birth in twin gestations: what is the next step forward? , 2013, BJOG: an International Journal of Obstetrics and Gynaecology.
[5] K. Nicolaides,et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. , 2012, American journal of obstetrics and gynecology.
[6] T. Garite,et al. Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. , 2010, American journal of obstetrics and gynecology.
[7] J. Thorp,et al. Prevention of Preterm Birth in Triplets Using 17 Alpha-Hydroxyprogesterone Caproate: A Randomized Controlled Trial , 2009, Obstetrics and gynecology.
[8] M. Klebanoff. Subgroup analysis in obstetrics clinical trials. , 2007, American journal of obstetrics and gynecology.
[9] K. Nicolaides,et al. Maternal characteristics and cervical length in the prediction of spontaneous early preterm delivery in twins. , 2006, American journal of obstetrics and gynecology.
[10] B. Mol,et al. 1: Pessaries in multiple pregnancy as a prevention of preterm birth (ProTWIN): a randomized controlled trial , 2012 .